Table 1.
Descriptive and demographic data of the study population
| EDA group n=40 |
ITM group n=40 |
|
| Age (years) | 59.0 (51.5–66.0) | 58.5 (54.0–62.5) |
| <50 years | 7 (17.5%) | 6 (15%) |
| 50–60 years | 16 (40%) | 20 (50%) |
| >60 years | 17 (42.5%) | 14 (35%) |
| Body mass index (BMI; kg/m2) | 28.5 (24.7–31.2) | 27.8 (23.4–31.2) |
| BMI <25 kg/m2 | 11 (27.5%) | 13 (32.5%) |
| BMI 25–29.9 kg/m2 | 15 (37.5%) | 15 (37.5%) |
| BMI 30–34.9 kg/m2 | 9 (22.5%) | 7 (17.5%) |
| BMI ≥35 kg/m2 | 5 (12.5%) | 5 (12.5%) |
| Parity | 2.0 (0–5) | 2.0 (0–4) |
| Smokers | 5 (12.5%) | 4 (10%) |
| Previous laparotomy | 17 (42.5%) | 17 (42.5%) |
| ASA classification | ||
| Class I | 15 (37.5%) | 15 (37.5%) |
| Class II | 25 (62.5%) | 25 (62.5%) |
| Comorbidity | ||
| Diabetes mellitus | 4 (10%) | 4 (10%) |
| Cardiovascular disease | 13 (32.5%) | 12 (30%) |
| Pulmonary disease | 4 (10%) | 5 (12.5%) |
| Mild psychiatric disease | 6 (12.5%) | 4 (10%) |
| Previous malignancy | 4 (10%) | 2 (5%) |
| Current medication | ||
| Antidepressant/sedative | 8 (20%) | 7 (17.5%) |
| Analgesics | 7 (17.5%) | 12 (30%) |
| Indication for surgery | ||
| Proven/assumed gynecological malignancy | 16/24 (40%/60%) | 18/22 (45%/55%) |
Figures denote median and (IQR) or number and (percent).
ASA, American Society of Anesthesiologists risk classification; EDA, epidural analgesia; ITM, intrathecal morphine analgesia.